Evidence map›Paper›PMID 41035993›Full record

ArticleOpen veterinary journal2025

Designated primers targeted canine

Fatimah Abdulmuttaleb Ali, Aoula Al-Zebeeby

Abstract read
In one paragraph

Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fatimah Abdulmuttaleb AliDepartment of Pathology and Poultry Diseases, Faculty of Veterinary Medicine, University of Kufa, Al-Najaf Al-Ashraf, Iraq.
Aoula Al-ZebeebyDepartment of Pathology and Poultry Diseases, Faculty of Veterinary Medicine, University of Kufa, Al-Najaf Al-Ashraf, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tumor protein 53 gene ( Aim: The main objective of this study was to design and evaluate the efficacy of three different primer sets that targeted the Methods: To do that, twelve blood samples were collected from dogs belonging to the German Shepherd breed/K9 aged between 8-12 years. Then, the DNA extraction and polymerase chain reaction (PCR) took place by using the three primer sets, which were designed using SnapGene. The primer sets, namely, first primer, the second and the third targeted exons 5-9 located in the canine TP53 gene. In the following step, all the PCR products were sent for Sanger sequencing and then phylogenetic analysis. Results: Our findings indicated that the first primer set consistently showed higher amplification signal efficiency and reduced dimer formation compared with the second and third primer sets, respectively, with a 60ºC annealing temperature. In addition, all the sequenced samples aligned with the reference canine Conclusion: This study offered the best

Indexed as

DNA PrimersGenes, p53Tumor Suppressor Protein p53AnimalsDogsFemalePhylogenyPolymerase Chain ReactionDNA PrimersTumor Suppressor Protein p53CanineExons 5-9PCRTP53 geneTP53 hot spot regions

Identifiers

PMID41035993
PMCPMC12483457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.